Key result
Aging of adipose tissue leads to its redistribution into visceral depots, increased proinflammatory potential, and decreased brown fat activity, contributing to metabolic disorders and cardiovascular risk.
Why the study?
Aging of adipose tissue alters metabolic and inflammatory profiles, contributing to insulin resistance, endothelial dysfunction, and increased cardiovascular risk, but its pathophysiological changes over time and clinical manifestations require review.
This review highlights the pathophysiological mechanisms of adipose tissue aging, emphasizing its role in metabolic dysfunction and cardiovascular disease risk.
Age-related adipose tissue redistribution may alter metabolic risk in older adults; leaves open age-specific intervention trials.
Adipose tissue is one of the most spread tissues; it forms fat depots, varied in their structural and functional characteristics. Adipose tissue is plastic. During human’s life, it undergoes many changes and restructuring. With age, the proportion of different types of adipose tissue and the microenvironment of adipocytes change, including the stromal component, immune cells and the microcirculation. In addition, energy storage strategies differ between younger and older adults. A redistribution of adipose tissue into visceral depots is observed even in patients with adequate body mass index. These changes aggravate metabolic disorders and contribute to insulin resistance. Along with increased proinflammatory potential and endothelial dysfunction, aging of adipose tissue increases the risk of cardiovascular outcomes. At the same time, the described changes are also observed in obesity, even in relatively young patients. It is assumed that the peculiarities of lipid accumulation due to adipocyte hypertrophy entail the development of dysfunction of adipose tissue, which is reflected in changes in its cytokine and hormonal profile. Such pathological processes are characteristic of the so-called “metabolically unhealthy” obesity.This review provides current knowledge about the changes that different types of adipose tissue undergo over time, as well as the connection between pathophysiological processes and clinical manifestations observed with aging and dysfunction of adipose tissue.
No takes yet. Share an insight, caveat, or question.
Семикова et al. (2025) conducted a review in Adipose tissue aging and obesity. Aging of adipose tissue leads to its redistribution into visceral depots, increased proinflammatory potential, and decreased brown fat activity, contributing to metabolic disorders and cardiovascular risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: